Mission
Based on extensive research in carbohydrate polymers and iron
carbohydrate complexes, Pharmacosmos persistently develops and
markets pharmaceuticals for intravenous iron injection and total
dose iron infusion therapy.
Pharmacosmos strives to be the preferred dextran supplier with
respect to product quality, purity, safety and efficacy. As an
important part of our business development, Pharmacosmos
participates in leading research activities, which may identify
novel applications of dextran and other carbohydrate polymers.
Veterinary iron dextran injection for prevention of piglet iron
deficiency anemia constitutes an important part of our activities.
Pharmacosmos will continuously engage in scientific studies to
further substantiate the effects of Uniferon® iron
dextran as iron supplement in piglets.
On the basis of extensive knowledge about carbohydrate and iron
carbohydrate chemistry, Pharmacosmos develops the new generation of
drug products for intravenous iron infusion used in treatment of
iron deficiency anemia.
Learn more about Pharmacosmos by reading our vision and
strategy.